Jeffrey A Meckler Insider Trading $RTRX Travere Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey A Meckler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey A Meckler. Jeffrey A Meckler is Director in QLT INC/BC ($QLTI) and in Cocrystal Pharma, Inc. ($BZNE) and CHIEF EXECUTIVE OFFICER in Cocrystal Pharma, Inc. ($BZNE) and Director in Retrophin, Inc. ($RTRX) and Chief Executive Officer in Intec Pharma Ltd. ($NTEC).
Jeffrey A Meckler in Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey A Meckler: Director
Holdings: 67,000 shares
Current Value: $1,344,690
Latest Transaction: May 18 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jeffrey A Meckler in Travere Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, COCP, NTEC, NVLN, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
| May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Grant | A | 0.00 | 3,000 | 0 | 67,000 | 64 K to 67 K (+4.69 %) |
| May 19 2020 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 3,000 | 0 | 64,000 | 61 K to 64 K (+4.92 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 61,000 | 59 K to 61 K (+3.39 %) |
| May 11 2018 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 26.52 | 10,000 | 265,200 | 10,000 | |
| May 11 2018 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,500 | 0 | 59,000 | 56.5 K to 59 K (+4.42 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,500 | 0 | 56,500 | 54 K to 56.5 K (+4.63 %) |
| May 19 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 16.33 | 8,000 | 130,640 | 8,000 | |
| May 19 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 54,000 | 52 K to 54 K (+3.85 %) |
| Mar 07 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Buy | P | 15.31 | 5,000 | 76,565 | 52,000 | 47 K to 52 K (+10.64 %) |
| Mar 03 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Buy | P | 14.45 | 10,000 | 144,500 | 47,000 | 37 K to 47 K (+27.03 %) |
| Jun 10 2015 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 32.59 | 8,000 | 260,720 | 8,000 | |
| Jun 10 2015 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 37,000 | 35 K to 37 K (+5.71 %) |
Page: 1